3-(2,6-Difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(4-morpholinylmethyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one(CAS: 1513857-77-6)

This compound is a crystalline solid with a molecular weight of approximately 461.27 g/mol. It has limited water solubility and high solubility in polar organic solvents like DMSO. Chemically, it is reactive towards nucleophiles and exhibits good stability under basic conditions but is susceptible to hydrolysis under acidic conditions. It is an important intermediate in the synthesis of various pharmaceuticals.

This compound is synthesized via a multi-step process involving the coupling of 2,6-difluoro-3,5-dimethoxybenzaldehyde and morpholine, followed by a condensation reaction using ethyl chloroformate. The synthesis yields a product with good purity, and the reaction is typically carried out under mild conditions to ensure high selectivity and yield.

This compound is primarily used in the pharmaceutical industry as a key intermediate in the synthesis of novel drugs. It may also find applications in the development of sensors and semiconductors, although its specific uses in these areas are limited.

When handling this compound, it is essential to wear appropriate personal protective equipment (PPE) including gloves, goggles, and a lab coat. Work should be conducted in a well-ventilated fume hood to minimize inhalation risks. Spills should be cleaned up using appropriate absorbent materials and disposed of according to local regulations. Always refer to the Safety Data Sheet (SDS) for detailed handling and disposal instructions.